US OptionsDetailed Quotes
RIGL241220C500
- 0.35
- 0.000.00%
15min DelayTrading Jun 25 10:55 ET
0.00High0.00Low
0.00Open0.35Pre Close0 Volume0 Open Interest0.50Strike Price0.00Turnover0.00%IV-95.60%PremiumDec 20, 2024Expiry Date18.80Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma55.14Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet